These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 28823401)

  • 41. Hepatic and intrahepatic targeting of an anti-inflammatory agent with human serum albumin and neoglycoproteins as carrier molecules.
    Franssen EJ; Jansen RW; Vaalburg M; Meijer DK
    Biochem Pharmacol; 1993 Mar; 45(6):1215-26. PubMed ID: 8466542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kinetic study of the hepatobiliary transport of a new prostaglandin receptor agonist.
    Imawaka H; Sugiyama Y
    J Pharmacol Exp Ther; 1998 Mar; 284(3):949-57. PubMed ID: 9495854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Presence of a Transporter-Induced Protein Binding Shift: A New Explanation for Protein-Facilitated Uptake and Improvement for In Vitro-In Vivo Extrapolation.
    Bowman CM; Okochi H; Benet LZ
    Drug Metab Dispos; 2019 Apr; 47(4):358-363. PubMed ID: 30674616
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extrapolating in vitro metabolic interactions to isolated perfused liver: predictions of metabolic interactions between R-bufuralol, bunitrolol, and debrisoquine.
    Haddad S; Poulin P; Funk C
    J Pharm Sci; 2010 Oct; 99(10):4406-26. PubMed ID: 20310018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kinetic determinants of hepatic clearance: plasma protein binding and hepatic uptake.
    Baker M; Parton T
    Xenobiotica; 2007; 37(10-11):1110-34. PubMed ID: 17968739
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between passive permeability, efflux, and predictability of clearance from in vitro metabolic intrinsic clearance.
    Huang L; Berry L; Ganga S; Janosky B; Chen A; Roberts J; Colletti AE; Lin MH
    Drug Metab Dispos; 2010 Feb; 38(2):223-31. PubMed ID: 19875499
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Using the concordance of in vitro and in vivo data to evaluate extrapolation assumptions.
    Honda GS; Pearce RG; Pham LL; Setzer RW; Wetmore BA; Sipes NS; Gilbert J; Franz B; Thomas RS; Wambaugh JF
    PLoS One; 2019; 14(5):e0217564. PubMed ID: 31136631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Membrane binding proteins are the major determinants for the hepatocellular transmembrane flux of long-chain fatty acids bound to albumin.
    Rajaraman G; Roberts MS; Hung D; Wang GQ; Burczynski FJ
    Pharm Res; 2005 Nov; 22(11):1793-804. PubMed ID: 16091995
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of albumin on hepatic uptake of warfarin in normal and analbuminemic mutant rats: analysis by multiple indicator dilution method.
    Tsao SC; Sugiyama Y; Sawada Y; Nagase S; Iga T; Hanano M
    J Pharmacokinet Biopharm; 1986 Feb; 14(1):51-64. PubMed ID: 3746632
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disposition of naproxen, naproxen acyl glucuronide and its rearrangement isomers in the isolated perfused rat liver.
    Lo A; Addison RS; Hooper WD; Dickinson RG
    Xenobiotica; 2001 Jun; 31(6):309-19. PubMed ID: 11513245
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro hepatic microsomal metabolism of meloxicam in koalas (Phascolarctos cinereus), brushtail possums (Trichosurus vulpecula), ringtail possums (Pseudocheirus peregrinus), rats (Rattus norvegicus) and dogs (Canis lupus familiaris).
    Kimble B; Li KM; Valtchev P; Higgins DP; Krockenberger MB; Govendir M
    Comp Biochem Physiol C Toxicol Pharmacol; 2014 Apr; 161():7-14. PubMed ID: 24345479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanistic modeling of hepatic transport from cells to whole body: application to napsagatran and fexofenadine.
    Poirier A; Funk C; Scherrmann JM; Lavé T
    Mol Pharm; 2009; 6(6):1716-33. PubMed ID: 19739673
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kinetics of hepatic transport of 4-methylumbelliferone in rats. Analysis by multiple indicator dilution method.
    Miyauchi S; Sugiyama Y; Sawada Y; Morita K; Iga T; Hanano M
    J Pharmacokinet Biopharm; 1987 Feb; 15(1):25-38. PubMed ID: 3305862
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of desorption kinetics from albumin on hepatic extraction efficiency and hepatic clearance: a model study.
    Krause S; Goss KU
    Arch Toxicol; 2018 Jul; 92(7):2175-2182. PubMed ID: 29796692
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A convenient in vitro screening method for predicting in vivo drug metabolic clearance using isolated hepatocytes suspended in serum.
    Shibata Y; Takahashi H; Ishii Y
    Drug Metab Dispos; 2000 Dec; 28(12):1518-23. PubMed ID: 11095592
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatic bilirubin uptake in the isolated perfused rat liver is not facilitated by albumin binding.
    Stollman YR; Gärtner U; Theilmann L; Ohmi N; Wolkoff AW
    J Clin Invest; 1983 Aug; 72(2):718-23. PubMed ID: 6308060
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of plasma protein binding on elimination of taurocholate by isolated perfused rat liver: comparison of venous equilibrium, undistributed and distributed sinusoidal, and dispersion models.
    Smallwood RH; Morgan DJ; Mihaly GW; Jones DB; Smallwood RA
    J Pharmacokinet Biopharm; 1988 Aug; 16(4):377-96. PubMed ID: 3193365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predicting metabolic clearance for drugs that are actively transported into hepatocytes: incubational binding as a consequence of in vitro hepatocyte concentration is a key factor.
    Nordell P; Svanberg P; Bird J; Grime K
    Drug Metab Dispos; 2013 Apr; 41(4):836-43. PubMed ID: 23364509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An examination of protein binding and protein-facilitated uptake relating to in vitro-in vivo extrapolation.
    Bowman CM; Benet LZ
    Eur J Pharm Sci; 2018 Oct; 123():502-514. PubMed ID: 30098391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In Vitro-In Vivo Extrapolation and Scaling Factors for Clearance of Human and Preclinical Species with Liver Microsomes and Hepatocytes.
    Tess D; Chang GC; Keefer C; Carlo A; Jones R; Di L
    AAPS J; 2023 Apr; 25(3):40. PubMed ID: 37052732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.